Galderma Group AG (GALDY)
38.91
+0.15
(+0.39%)
USD |
OTCM |
Oct 05, 16:00
Galderma Group Market Cap : 45.37B for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 45.37B |
| October 02, 2026 | 45.19B |
| October 01, 2026 | 45.24B |
| September 30, 2026 | 46.16B |
| September 29, 2026 | 46.49B |
| September 28, 2026 | 45.59B |
| September 25, 2026 | 46.00B |
| September 24, 2026 | 45.86B |
| September 23, 2026 | 45.30B |
| September 22, 2026 | 46.44B |
| September 21, 2026 | 45.64B |
| September 18, 2026 | 44.88B |
| September 17, 2026 | 44.47B |
| September 16, 2026 | 43.27B |
| September 15, 2026 | 43.34B |
| September 14, 2026 | 44.32B |
| September 11, 2026 | 44.03B |
| September 10, 2026 | 43.91B |
| September 09, 2026 | 44.62B |
| September 08, 2026 | 46.42B |
| September 04, 2026 | 45.51B |
| September 03, 2026 | 47.00B |
| September 02, 2026 | 47.50B |
| September 01, 2026 | 47.65B |
| August 31, 2026 | 48.26B |
| Date | Value |
|---|---|
| August 28, 2026 | 49.38B |
| August 27, 2026 | 49.55B |
| August 26, 2026 | 49.42B |
| August 25, 2026 | 49.95B |
| August 24, 2026 | 49.54B |
| August 21, 2026 | 49.91B |
| August 20, 2026 | 49.13B |
| August 19, 2026 | 50.24B |
| August 18, 2026 | 48.54B |
| August 17, 2026 | 48.57B |
| August 14, 2026 | 49.49B |
| August 13, 2026 | 51.22B |
| August 12, 2026 | 50.49B |
| August 11, 2026 | 50.46B |
| August 10, 2026 | 50.42B |
| August 07, 2026 | 52.36B |
| August 06, 2026 | 51.17B |
| August 05, 2026 | 51.32B |
| August 04, 2026 | 50.42B |
| August 03, 2026 | 50.10B |
| July 31, 2026 | 50.84B |
| July 30, 2026 | 52.58B |
| July 29, 2026 | 50.38B |
| July 28, 2026 | 50.43B |
| July 27, 2026 | 49.49B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sandoz Group AG | 36.58B |
| Novartis AG | 257.66B |
| Roche Holding AG | 289.89B |
| Addex Therapeutics Ltd. | 3.377M |
| Oculis Holding AG | 538.30M |
Market Cap Related Metrics
| PE Ratio | 53.11 |
| PS Ratio | 7.778 |
| Price to Free Cash Flow | 43.43 |
| Price | 38.91 |
| Earnings Yield | 1.88% |
| Operating PE Ratio | 41.97 |
| Normalized PE Ratio | 49.57 |